Attention-Deficit/Hyperactivity Disorder Symptoms, Sensation-Seeking, and Sensory Modulation Dysfunction in Substance Use Disorder: A Cross Sectional Two-Group Comparative Study.
ADHD
SUD
risk factor
sensation-seeking
sensory over-responsiveness
sensory processing
therapeutic community
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
22 02 2022
22 02 2022
Historique:
received:
23
01
2022
revised:
12
02
2022
accepted:
14
02
2022
entrez:
10
3
2022
pubmed:
11
3
2022
medline:
16
4
2022
Statut:
epublish
Résumé
Attention-deficit/hyperactivity disorder (ADHD) and sensation-seeking, a trait characterized by risk-related behaviors, have been recognized as risk factors in substance use disorder (SUD). Though ADHD co-occurs with sensory modulation dysfunction (SMD), SMD has scarcely been explored in SUD. Thus, this study aimed to characterize ADHD symptomology, sensation-seeking, and SMD, as well as to explore their contribution to SUD likelihood. A cross sectional two-group comparative study including therapeutic community residents with SUD ( The study group demonstrated higher SMD incidence (53.57% vs. 14.52%) and lower performance in three MOXO-CPT indexes: Attention, Impulsivity, and Hyperactivity, but not in Timing, compared to the comparison group. Sensory over-responsiveness had the strongest relationship with SUD, indicating 27-times increased odds for SUD (95% CI = 5.965, 121.216; We found SMD with the strongest relation to SUD exceeding that of ADHD, thus contributing a new perspective for developing future therapeutic modalities. Our findings highlight the need to address SMD above and beyond ADHD symptomology throughout the SUD rehabilitation.
Sections du résumé
BACKGROUND
Attention-deficit/hyperactivity disorder (ADHD) and sensation-seeking, a trait characterized by risk-related behaviors, have been recognized as risk factors in substance use disorder (SUD). Though ADHD co-occurs with sensory modulation dysfunction (SMD), SMD has scarcely been explored in SUD. Thus, this study aimed to characterize ADHD symptomology, sensation-seeking, and SMD, as well as to explore their contribution to SUD likelihood.
METHODS
A cross sectional two-group comparative study including therapeutic community residents with SUD (
RESULTS
The study group demonstrated higher SMD incidence (53.57% vs. 14.52%) and lower performance in three MOXO-CPT indexes: Attention, Impulsivity, and Hyperactivity, but not in Timing, compared to the comparison group. Sensory over-responsiveness had the strongest relationship with SUD, indicating 27-times increased odds for SUD (95% CI = 5.965, 121.216;
CONCLUSION
We found SMD with the strongest relation to SUD exceeding that of ADHD, thus contributing a new perspective for developing future therapeutic modalities. Our findings highlight the need to address SMD above and beyond ADHD symptomology throughout the SUD rehabilitation.
Identifiants
pubmed: 35270233
pii: ijerph19052541
doi: 10.3390/ijerph19052541
pmc: PMC8909105
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Int J Methods Psychiatr Res. 2013 Sep;22(3):232-44
pubmed: 24022983
Psychol Med. 2005 Feb;35(2):245-56
pubmed: 15841682
Arch Clin Neuropsychol. 2017 Feb;32(1):81-93
pubmed: 28122767
Am J Occup Ther. 1995 May;49(5):444-51
pubmed: 7598160
Am J Occup Ther. 2011 May-Jun;65(3):320-7
pubmed: 21675338
Res Dev Disabil. 2015 Oct-Nov;45-46:157-67
pubmed: 26254166
Am J Addict. 2021 Mar;30(2):110-121
pubmed: 33289928
Psychodyn Psychiatry. 2015 Jun;43(2):243-75
pubmed: 26039231
Isr Med Assoc J. 2010 Sep;12(9):531-5
pubmed: 21287795
Res Dev Disabil. 2012 May-Jun;33(3):804-18
pubmed: 22236629
Eur Addict Res. 2020;26(3):151-162
pubmed: 32074617
J Pain. 2018 Aug;19(8):943-951
pubmed: 29597079
Pain Pract. 2018 Apr;18(4):473-486
pubmed: 28782305
Pediatr Res. 2019 Aug;86(2):221-226
pubmed: 30986817
J Youth Adolesc. 2017 Sep;46(9):1953-1967
pubmed: 28220280
Ann Clin Psychiatry. 2006 Jul-Sep;18(3):145-8
pubmed: 16923651
J Psychoactive Drugs. 2018 Apr-Jun;50(2):177-186
pubmed: 29125424
Subst Abus. 2021;42(4):998-1006
pubmed: 33750274
Am J Occup Ther. 2007 Mar-Apr;61(2):135-40
pubmed: 17436834
J Atten Disord. 2011 Oct;15(7):557-63
pubmed: 20837987
Eur Addict Res. 2020;26(4-5):233-244
pubmed: 32564034
J Neurosci Methods. 2014 Jan 30;222:62-8
pubmed: 24211249
Addict Behav. 2013 Jan;38(1):1457-63
pubmed: 23017733
Pain Med. 2020 Sep 1;21(9):1902-1912
pubmed: 31782772
JAMA Psychiatry. 2017 May 1;74(5):520-527
pubmed: 28384801
Subst Abus. 2008;29(3):81-7
pubmed: 19042209
J Am Acad Child Adolesc Psychiatry. 2011 Jun;50(6):543-53
pubmed: 21621138
Front Integr Neurosci. 2019 Jul 18;13:27
pubmed: 31379526
PLoS One. 2018 Aug 9;13(8):e0201354
pubmed: 30091986
Int J Methods Psychiatr Res. 2007;16(2):52-65
pubmed: 17623385
Subst Use Misuse. 2019;54(4):538-548
pubmed: 30729882
Front Hum Neurosci. 2013 Dec 16;7:862
pubmed: 24379772
Disabil Rehabil. 2009;31(3):189-201
pubmed: 18608365
Phys Occup Ther Pediatr. 2017 Aug;37(3):322-331
pubmed: 27366925
Drug Alcohol Depend. 2012 Apr 1;122(1-2):11-9
pubmed: 22209385
Curr Opin Neurobiol. 2017 Apr;43:25-34
pubmed: 27918886
Am J Occup Ther. 2016 Jul-Aug;70(4):7004250010
pubmed: 27294988
Curr Psychiatry Rep. 2014 Mar;16(3):436
pubmed: 24526271
J Subst Abuse Treat. 2017 Jul;78:48-55
pubmed: 28554603
J Behav Med. 2010 Dec;33(6):474-85
pubmed: 20625809
J Pers Med. 2021 Feb 02;11(2):
pubmed: 33540769
Atten Defic Hyperact Disord. 2017 Mar;9(1):47-65
pubmed: 27866355
Behav Brain Res. 1996 May;77(1-2):23-43
pubmed: 8762157
Addict Behav Rep. 2017 Sep 04;6:96-101
pubmed: 29450242
Addict Behav. 2017 Jul;70:72-78
pubmed: 28214739
Pain Res Manag. 2021 Nov 11;2021:5527261
pubmed: 34804266
J Abnorm Child Psychol. 2013 Jan;41(1):27-41
pubmed: 22752720
Am J Occup Ther. 2019 Jan/Feb;73(1):7301205100p1-7301205100p11
pubmed: 30839265
Eur Addict Res. 2020;26(4-5):173-178
pubmed: 32599579
J Subst Abuse Treat. 2014 Jul;47(1):58-72
pubmed: 24629886
Res Dev Disabil. 2015 Feb;37:17-30
pubmed: 25460216
Behav Brain Res. 2010 Mar 5;207(2):215-22
pubmed: 19751771
Neurosci Biobehav Rev. 2008;32(4):777-810
pubmed: 18295884
Addict Health. 2015 Summer-Autumn;7(3-4):174-83
pubmed: 26885354
Res Dev Disabil. 2020 May;100:103608
pubmed: 32087509
Drug Alcohol Rev. 2015 Mar;34(2):119-34
pubmed: 24684591
Aust N Z J Psychiatry. 2021 Aug;55(8):744-746
pubmed: 33908263
PLoS One. 2014 Aug 27;9(8):e105640
pubmed: 25162629
OTJR (Thorofare N J). 2016 Apr;36(2 Suppl):3S-26S
pubmed: 27504990
Drug Alcohol Depend. 2014 Jan 1;134:158-166
pubmed: 24156882
Psychopharmacology (Berl). 2007 Mar;190(4):517-30
pubmed: 17136401
J Psychiatr Res. 2017 Feb;85:49-55
pubmed: 27835739
Brain Sci. 2021 Feb 02;11(2):
pubmed: 33540665
Dev Med Child Neurol. 2008 Dec;50(12):932-7
pubmed: 19046186